id	sid	eid	entity	type
fsns-1447	1	1	2573-1661	CARDINAL
fsns-1447	1	2	issn 2573-167x	PERSON
fsns-1447	2	1	2	CARDINAL
fsns-1447	2	2	2, 2018	DATE
fsns-1447	2	3	12	CARDINAL
fsns-1447	3	1	kitayama1	PERSON
fsns-1447	3	2	mina yamamoto1	ORG
fsns-1447	3	3	kono1	PERSON
fsns-1447	3	4	yamada1 &	ORG
fsns-1447	3	5	nomura1 1	ORG
fsns-1447	3	6	kindai university	ORG
fsns-1447	3	7	japan	GPE
fsns-1447	3	8	yoshiyuki watanabe	PERSON
fsns-1447	3	9	kindai university	ORG
fsns-1447	3	10	739-2116	QUANTITY
fsns-1447	3	11	japan	GPE
fsns-1447	3	12	may 16, 2018	DATE
fsns-1447	3	13	may 22, 2018	DATE
fsns-1447	3	14	june 4, 2018	DATE
fsns-1447	7	1	-amylase	PERSON
fsns-1447	7	2	-glucosidase	ORG
fsns-1447	8	1	3t3	CARDINAL
fsns-1447	12	1	1	CARDINAL
fsns-1447	14	1	annual	DATE
fsns-1447	14	2	south asia	LOC
fsns-1447	16	1	more than 60%	PERCENT
fsns-1447	16	2	-linolenic	ORG
fsns-1447	16	3	2006	DATE
fsns-1447	17	1	-linolenic	ORG
fsns-1447	18	1	2	CARDINAL
fsns-1447	18	2	2	CARDINAL
fsns-1447	18	3	2018 13	DATE
fsns-1447	18	4	scholink inc.	ORG
fsns-1447	21	1	more than 4,000	CARDINAL
fsns-1447	22	1	2015	DATE
fsns-1447	22	2	lu et al.	PERSON
fsns-1447	22	3	2016	DATE
fsns-1447	25	1	2	CARDINAL
fsns-1447	26	1	3	CARDINAL
fsns-1447	26	2	3.1	CARDINAL
fsns-1447	26	3	bussan shakunagekan	PERSON
fsns-1447	26	4	hiroshima	GPE
fsns-1447	26	5	japan	GPE
fsns-1447	27	1	caffeic	PERSON
fsns-1447	27	2	2-morpholinoethane	QUANTITY
fsns-1447	27	3	folin	GPE
fsns-1447	27	4	3	CARDINAL
fsns-1447	27	5	ibm	ORG
fsns-1447	27	6	cii	ORG
fsns-1447	27	7	osaka	GPE
fsns-1447	27	8	japan	GPE
fsns-1447	28	1	±	CARDINAL
fsns-1447	28	2	-amylase	PERSON
fsns-1447	28	3	st. louis	GPE
fsns-1447	28	4	mo, usa	GPE
fsns-1447	29	1	merck-millipore co.	ORG
fsns-1447	29	2	darmstadt	GPE
fsns-1447	29	3	germany	GPE
fsns-1447	30	1	1,1	CARDINAL
fsns-1447	30	2	tokyo	GPE
fsns-1447	30	3	tokyo	GPE
fsns-1447	30	4	japan	GPE
fsns-1447	31	1	thermofisher scientific inc.	ORG
fsns-1447	31	2	waltham	GPE
fsns-1447	31	3	ma, usa	ORG
fsns-1447	31	4	boehringer ingelheim gmbh	ORG
fsns-1447	31	5	ingelheim	GPE
fsns-1447	31	6	germany	GPE
fsns-1447	32	1	3t3	CARDINAL
fsns-1447	32	2	the japan human science foundation (	ORG
fsns-1447	32	3	tokyo	GPE
fsns-1447	32	4	japan	GPE
fsns-1447	34	1	tokyo	GPE
fsns-1447	34	2	japan	GPE
fsns-1447	35	1	hydroxymethyl methyl-2-aminoethane	PERSON
fsns-1447	35	2	kumamoto	GPE
fsns-1447	35	3	japan	GPE
fsns-1447	36	1	osaka	GPE
fsns-1447	36	2	japan	GPE
fsns-1447	37	1	3.2	CARDINAL
fsns-1447	37	2	20	CARDINAL
fsns-1447	37	3	300 ml	QUANTITY
fsns-1447	37	4	95°	QUANTITY
fsns-1447	37	5	10 min	DATE
fsns-1447	38	1	2	CARDINAL
fsns-1447	38	2	2	CARDINAL
fsns-1447	38	3	2018 14	DATE
fsns-1447	38	4	scholink inc.	ORG
fsns-1447	38	5	100	CARDINAL
fsns-1447	38	6	1	CARDINAL
fsns-1447	38	7	7 days	DATE
fsns-1447	40	1	1	CARDINAL
fsns-1447	40	2	2003	DATE
fsns-1447	41	1	yamato scientific co., ltd.	ORG
fsns-1447	41	2	tokyo	GPE
fsns-1447	41	3	japan	GPE
fsns-1447	42	1	0.2 ml	QUANTITY
fsns-1447	42	2	12	CARDINAL
fsns-1447	42	3	0.2 mol/l	QUANTITY
fsns-1447	42	4	7.5	CARDINAL
fsns-1447	42	5	0.2 mol/l	QUANTITY
fsns-1447	42	6	3	CARDINAL
fsns-1447	42	7	3	CARDINAL
fsns-1447	42	8	1	CARDINAL
fsns-1447	42	9	3.3	CARDINAL
fsns-1447	42	10	al.	PERSON
fsns-1447	42	11	2006	DATE
fsns-1447	43	1	15 ml	QUANTITY
fsns-1447	43	2	0.4 mm	QUANTITY
fsns-1447	43	3	15 ml	QUANTITY
fsns-1447	43	4	0.2	CARDINAL
fsns-1447	43	5	6.0	CARDINAL
fsns-1447	43	6	3.4	CARDINAL
fsns-1447	44	1	six	CARDINAL
fsns-1447	44	2	13.7	CARDINAL
fsns-1447	45	1	600	CARDINAL
fsns-1447	45	2	1.8 ml	QUANTITY
fsns-1447	47	1	20 min	TIME
fsns-1447	47	2	25°	QUANTITY
fsns-1447	48	1	520	CARDINAL
fsns-1447	48	2	dr4000	PRODUCT
fsns-1447	48	3	hach co.	ORG
fsns-1447	48	4	loveland	GPE
fsns-1447	48	5	13.7	CARDINAL
fsns-1447	49	1	2	CARDINAL
fsns-1447	49	2	2	CARDINAL
fsns-1447	49	3	2018 15	DATE
fsns-1447	49	4	scholink inc.	ORG
fsns-1447	50	1	100	CARDINAL
fsns-1447	51	1		GPE
fsns-1447	52	1	1979	DATE
fsns-1447	53	1	0.1	CARDINAL
fsns-1447	53	2	352.9	CARDINAL
fsns-1447	54	1	50	CARDINAL
fsns-1447	54	2	500	CARDINAL
fsns-1447	54	3	500	CARDINAL
fsns-1447	54	4	37°	QUANTITY
fsns-1447	55	1	560	CARDINAL
fsns-1447	56	1	folin	GPE
fsns-1447	56	2	kähkönen et al.	PERSON
fsns-1447	56	3	1999	DATE
fsns-1447	57	1	folin	PERSON
fsns-1447	57	2	1 ml	QUANTITY
fsns-1447	57	3	1 ml	QUANTITY
fsns-1447	57	4	3 min	TIME
fsns-1447	58	1	1 ml	QUANTITY
fsns-1447	58	2	10%	PERCENT
fsns-1447	58	3	1	CARDINAL
fsns-1447	58	4	3,000	CARDINAL
fsns-1447	58	5	10 min	TIME
fsns-1447	58	6	760	CARDINAL
fsns-1447	60	1	3.4	CARDINAL
fsns-1447	60	2	-amylase	PERSON
fsns-1447	60	3	-glucosidase	ORG
fsns-1447	60	4	2004	DATE
fsns-1447	60	5	hara & honda	ORG
fsns-1447	60	6	1990	DATE
fsns-1447	60	7	mcdougall et al.	PERSON
fsns-1447	60	8	2005	DATE
fsns-1447	60	9	saito et al.	PERSON
fsns-1447	60	10	2007	DATE
fsns-1447	61	1	first	ORDINAL
fsns-1447	61	2	5.35	CARDINAL
fsns-1447	61	3	250 mm	QUANTITY
fsns-1447	61	4	7.0	CARDINAL
fsns-1447	62	1	1 ml	QUANTITY
fsns-1447	62	2	100 l	CARDINAL
fsns-1447	62	3	37°	QUANTITY
fsns-1447	62	4	5 min	TIME
fsns-1447	63	1	20 l	QUANTITY
fsns-1447	63	2	-amylase	PERSON
fsns-1447	63	3	7.5 min	TIME
fsns-1447	64	1	660	CARDINAL
fsns-1447	64	2	1 ml	QUANTITY
fsns-1447	66	1	-glucosidase	ORG
fsns-1447	66	2	anno et al.	PERSON
fsns-1447	66	3	2004	DATE
fsns-1447	67	1	mcdougall et al.	PERSON
fsns-1447	67	2	2005	DATE
fsns-1447	67	3	saito et al.	PERSON
fsns-1447	67	4	2007	DATE
fsns-1447	67	5	2	CARDINAL
fsns-1447	67	6	45 ml	QUANTITY
fsns-1447	67	7	56 mm	QUANTITY
fsns-1447	67	8	6.0	CARDINAL
fsns-1447	68	1	3,000	CARDINAL
fsns-1447	68	2	4°	QUANTITY
fsns-1447	68	3	10 min	DATE
fsns-1447	69	1	50	CARDINAL
fsns-1447	69	2	2%	PERCENT
fsns-1447	69	3	37°	QUANTITY
fsns-1447	69	4	1	CARDINAL
fsns-1447	69	5	60°	QUANTITY
fsns-1447	69	6	10 min	DATE
fsns-1447	69	7	cii	ORG
fsns-1447	70	1	20	CARDINAL
fsns-1447	70	2	3 ml	QUANTITY
fsns-1447	70	3	37°	QUANTITY
fsns-1447	70	4	5 min	DATE
fsns-1447	70	5	505	CARDINAL
fsns-1447	71	1	80 mg	QUANTITY
fsns-1447	71	2	10 mg lecithin	QUANTITY
fsns-1447	72	1	2	CARDINAL
fsns-1447	72	2	2	CARDINAL
fsns-1447	72	3	2018 16	DATE
fsns-1447	72	4	scholink inc.	ORG
fsns-1447	72	5	5 mg	QUANTITY
fsns-1447	72	6	9 ml	QUANTITY
fsns-1447	72	7	0.1	CARDINAL
fsns-1447	72	8	7.0	CARDINAL
fsns-1447	72	9	0.1 m	QUANTITY
fsns-1447	72	10	2008	DATE
fsns-1447	72	11	kwon et al.	PERSON
fsns-1447	72	12	2003	DATE
fsns-1447	74	1	50	CARDINAL
fsns-1447	74	2	10	CARDINAL
fsns-1447	74	3	25 l	DATE
fsns-1447	74	4	125	CARDINAL
fsns-1447	74	5	37°	QUANTITY
fsns-1447	74	6	30 min	TIME
fsns-1447	76	1	37°	QUANTITY
fsns-1447	76	2	20 min	DATE
fsns-1447	76	3	550	CARDINAL
fsns-1447	77	1	3.5	CARDINAL
fsns-1447	77	2	3t3	CARDINAL
fsns-1447	77	3	3t3	CARDINAL
fsns-1447	77	4	2004	DATE
fsns-1447	78	1	hayashi et al.	PERSON
fsns-1447	78	2	1981	DATE
fsns-1447	78	3	iwashita et al.	PERSON
fsns-1447	78	4	2001	DATE
fsns-1447	78	5	kuri-harcuch & green	ORG
fsns-1447	78	6	1978	DATE
fsns-1447	78	7	1998	DATE
fsns-1447	79	1	3t3	CARDINAL
fsns-1447	79	2	96	CARDINAL
fsns-1447	79	3	1	CARDINAL
fsns-1447	79	4	20%	PERCENT
fsns-1447	79	5	under 5%	PERCENT
fsns-1447	80	1	37°	QUANTITY
fsns-1447	81	1	0.2 m	QUANTITY
fsns-1447	81	2	0.5 mm	QUANTITY
fsns-1447	81	3	ibm	ORG
fsns-1447	81	4	0.8	CARDINAL
fsns-1447	81	5	37°	QUANTITY
fsns-1447	81	6	2 days	DATE
fsns-1447	82	1	20%	PERCENT
fsns-1447	82	2	0.8	CARDINAL
fsns-1447	82	3	2-4 days	DATE
fsns-1447	83	1	10% to 4%	PERCENT
fsns-1447	83	2	2 days	DATE
fsns-1447	84	1	150	CARDINAL
fsns-1447	84	2	150	CARDINAL
fsns-1447	84	3	5-500	CARDINAL
fsns-1447	84	4	4%	PERCENT
fsns-1447	84	5	37°	QUANTITY
fsns-1447	85	1	3t3	CARDINAL
fsns-1447	85	2	kuri-harcuch & green	ORG
fsns-1447	85	3	1978	DATE
fsns-1447	86	1	first	ORDINAL
fsns-1447	86	2	500 mg	QUANTITY
fsns-1447	86	3	100 ml	QUANTITY
fsns-1447	87	1	60%	PERCENT
fsns-1447	87	2	10 min	TIME
fsns-1447	88	1	15 min	TIME
fsns-1447	88	2	10%	PERCENT
fsns-1447	89	1	60%	PERCENT
fsns-1447	89	2	1 min	TIME
fsns-1447	89	3	15 min	TIME
fsns-1447	90	1	ix72	ORG
fsns-1447	90	2	olympus co.	ORG
fsns-1447	90	3	tokyo	GPE
fsns-1447	90	4	japan	GPE
fsns-1447	91	1	3.6	CARDINAL
fsns-1447	91	2	two	QUANTITY
fsns-1447	91	3	50	CARDINAL
fsns-1447	91	4	50	CARDINAL
fsns-1447	91	5	200 mg	QUANTITY
fsns-1447	91	6	36 ml	QUANTITY
fsns-1447	93	1	3 mm	QUANTITY
fsns-1447	93	2	3 mm	QUANTITY
fsns-1447	93	3	5 cm	QUANTITY
fsns-1447	94	1	44%	PERCENT
fsns-1447	95	1	75°	QUANTITY
fsns-1447	95	2	5 days	DATE
fsns-1447	97	1	35	CARDINAL
fsns-1447	97	2	84 ml	QUANTITY
fsns-1447	97	3	3 min	TIME
fsns-1447	98	1	40°	QUANTITY
fsns-1447	98	2	10 min	DATE
fsns-1447	98	3	3,000	CARDINAL
fsns-1447	98	4	10 min	DATE
fsns-1447	99	1	three	CARDINAL
fsns-1447	99	2	three	CARDINAL
fsns-1447	101	1	2	CARDINAL
fsns-1447	101	2	2	CARDINAL
fsns-1447	101	3	2018 17	DATE
fsns-1447	101	4	scholink inc.	ORG
fsns-1447	103	1	3.7	CARDINAL
fsns-1447	104	1	0.05	CARDINAL
fsns-1447	105	1	4	CARDINAL
fsns-1447	105	2	4.1	CARDINAL
fsns-1447	105	3	100	CARDINAL
fsns-1447	105	4	0.958	CARDINAL
fsns-1447	105	5	0.254	CARDINAL
fsns-1447	105	6	0.885	CARDINAL
fsns-1447	105	7	2.66	CARDINAL
fsns-1447	105	8	0.325	CARDINAL
fsns-1447	109	1	0.02 0.040	QUANTITY
fsns-1447	111	1	100	CARDINAL
fsns-1447	112	1	10 102 103	CARDINAL
fsns-1447	112	2	2	CARDINAL
fsns-1447	114	1	the 50 mg/ml	QUANTITY
fsns-1447	114	2	2	CARDINAL
fsns-1447	115	1	50%	PERCENT
fsns-1447	115	2	sc50	PRODUCT
fsns-1447	115	3	35	CARDINAL
fsns-1447	115	4	7.7	CARDINAL
fsns-1447	115	5	41	CARDINAL
fsns-1447	116	1	sc50	PRODUCT
fsns-1447	116	2	50%	PERCENT
fsns-1447	117	1	5.6	CARDINAL
fsns-1447	117	2	8.3	CARDINAL
fsns-1447	118	1	2	CARDINAL
fsns-1447	118	2	2	CARDINAL
fsns-1447	118	3	2018 18	DATE
fsns-1447	118	4	scholink inc	ORG
fsns-1447	121	1	2	CARDINAL
fsns-1447	121	2	50	CARDINAL
fsns-1447	124	1	3	CARDINAL
fsns-1447	125	1	almost half	CARDINAL
fsns-1447	128	1	0	CARDINAL
fsns-1447	128	2	o	DATE
fsns-1447	128	3	0.4	CARDINAL
fsns-1447	128	4	3	CARDINAL
fsns-1447	128	5	sod)-like	ORG
fsns-1447	129	1	4.2	CARDINAL
fsns-1447	129	2	-amylase	PERSON
fsns-1447	129	3	-glucosidase	ORG
fsns-1447	130	1	4	CARDINAL
fsns-1447	131	1	50%	PERCENT
fsns-1447	131	2	ic50	ORG
fsns-1447	131	3	1.7 mg/ml	QUANTITY
fsns-1447	132	1	ic50	ORG
fsns-1447	132	2	catechin	ORG
fsns-1447	132	3	55 g	QUANTITY
fsns-1447	132	4	-amylase	PERSON
fsns-1447	133	1	-glucosidase	ORG
fsns-1447	133	2	4	CARDINAL
fsns-1447	134	1	ic50	ORG
fsns-1447	134	2	1.8 mg/ml	QUANTITY
fsns-1447	135	1	-glucosidase	ORG
fsns-1447	137	1	2	CARDINAL
fsns-1447	137	2	2	CARDINAL
fsns-1447	137	3	2018 19	DATE
fsns-1447	137	4	scholink inc.	ORG
fsns-1447	138	1	io	LOC
fsns-1447	139	1	60 40	CARDINAL
fsns-1447	140	1	0	CARDINAL
fsns-1447	140	2	4	CARDINAL
fsns-1447	140	3	-amylase	PERSON
fsns-1447	140	4	-glucosidase	ORG
fsns-1447	141	1	2	CARDINAL
fsns-1447	141	2	3t3	CARDINAL
fsns-1447	142	1	500 g	QUANTITY
fsns-1447	142	2	1	CARDINAL
fsns-1447	147	1	3t3	CARDINAL
fsns-1447	148	1	2	CARDINAL
fsns-1447	149	1	2	CARDINAL
fsns-1447	150	1	500 g/ml	QUANTITY
fsns-1447	150	2	1.8-1.9-fold	QUANTITY
fsns-1447	151	1	500 g	QUANTITY
fsns-1447	151	2	2.6	CARDINAL
fsns-1447	156	1	2	CARDINAL
fsns-1447	156	2	2	CARDINAL
fsns-1447	156	3	2018 20	DATE
fsns-1447	156	4	scholink inc.	ORG
fsns-1447	156	5	1	CARDINAL
fsns-1447	156	6	500 mg/ml	QUANTITY
fsns-1447	156	7	17.4	CARDINAL
fsns-1447	156	8	5.8 + 1.3	CARDINAL
fsns-1447	156	9	37.5 + 1.3	CARDINAL
fsns-1447	156	10	4.9 + 3.8	QUANTITY
fsns-1447	157	1	2	CARDINAL
fsns-1447	157	2	3t3	CARDINAL
fsns-1447	158	1	1	CARDINAL
fsns-1447	159	1	0.046 + 0.034	CARDINAL
fsns-1447	159	2	2	CARDINAL
fsns-1447	159	3	0.070	CARDINAL
fsns-1447	160	1	0.015	CARDINAL
fsns-1447	160	2	5	CARDINAL
fsns-1447	160	3	500	CARDINAL
fsns-1447	161	1	0.094 + 0.026 500	MONEY
fsns-1447	161	2	4.3	MONEY
fsns-1447	162	1	75°	QUANTITY
fsns-1447	163	1	5	CARDINAL
fsns-1447	164	1	5 days	DATE
fsns-1447	165	1	only about 10%	PERCENT
fsns-1447	166	1	close to zero	CARDINAL
fsns-1447	167	1	2	CARDINAL
fsns-1447	167	2	2	CARDINAL
fsns-1447	167	3	2018 21	DATE
fsns-1447	167	4	scholink inc.	ORG
fsns-1447	171	1	0.2 0.4 0.6	QUANTITY
fsns-1447	173	1	0.2 0.4 0.6	QUANTITY
fsns-1447	173	2	5	CARDINAL
fsns-1447	173	3	5 days	DATE
fsns-1447	173	4	44%	PERCENT
fsns-1447	173	5	-glucosidase	ORG
fsns-1447	173	6	6	CARDINAL
fsns-1447	175	1	35%	PERCENT
fsns-1447	175	2	2 mg/ml	QUANTITY
fsns-1447	176	1	5 days	DATE
fsns-1447	178	1	2	CARDINAL
fsns-1447	178	2	2	CARDINAL
fsns-1447	178	3	2018 22	DATE
fsns-1447	178	4	scholink inc	ORG
fsns-1447	178	5	0 20 40 60	CARDINAL
fsns-1447	178	6	io	LOC
fsns-1447	178	7	0 1 2	MONEY
fsns-1447	178	8	6	CARDINAL
fsns-1447	179	1	-glucosidase	ORG
fsns-1447	179	2	5 days	DATE
fsns-1447	179	3	44%	PERCENT
fsns-1447	179	4	7	CARDINAL
fsns-1447	179	5	75°	QUANTITY
fsns-1447	179	6	44%	PERCENT
fsns-1447	179	7	5 days	DATE
fsns-1447	182	1	zero	CARDINAL
fsns-1447	185	1	io	LOC
fsns-1447	185	2	0 day 5 day	DATE
fsns-1447	185	3	0 day 5 day	DATE
fsns-1447	185	4	0 day 5	DATE
fsns-1447	185	5	7	CARDINAL
fsns-1447	185	6	44%	PERCENT
fsns-1447	185	7	5 days	DATE
fsns-1447	186	1	2	CARDINAL
fsns-1447	186	2	2	CARDINAL
fsns-1447	186	3	2018 23	DATE
fsns-1447	186	4	scholink inc.	ORG
fsns-1447	186	5	5	CARDINAL
fsns-1447	191	1	t., tamura	PERSON
fsns-1447	191	2	k.	PERSON
fsns-1447	191	3	h., & tomi	ORG
fsns-1447	192	1	-amylase	PERSON
fsns-1447	192	2	japanese	NORP
fsns-1447	193	1	223	CARDINAL
fsns-1447	194	1	https://doi.org/10.5891/jafps.30.223 edashige	PERSON
fsns-1447	194	2	n., & tsujita	ORG
fsns-1447	194	3	t.	GPE
fsns-1447	194	4	2008	DATE
fsns-1447	196	1	54	DATE
fsns-1447	196	2	409	CARDINAL
fsns-1447	197	1	https://doi.org/10.3177/jnsv.54.409 fujita	PERSON
fsns-1447	197	2	a.	PERSON
fsns-1447	197	3	masumoto	PERSON
fsns-1447	197	4	kawakami	PERSON
fsns-1447	197	5	k.	PERSON
fsns-1447	197	6	mikami	PERSON
fsns-1447	197	7	t., & nomura	ORG
fsns-1447	197	8	m. (	PERSON
fsns-1447	197	9	2006	DATE
fsns-1447	199	1	585-591	CARDINAL
fsns-1447	200	1	furuyashiki	PERSON
fsns-1447	200	2	t.	GPE
fsns-1447	200	3	nagayasu, h.	ORG
fsns-1447	200	4	aoki	PERSON
fsns-1447	200	5	k., & ashida	ORG
fsns-1447	201	1	2	CARDINAL
fsns-1447	201	2	c/ebp	ORG
fsns-1447	201	3	3t3	CARDINAL
fsns-1447	202	1	68(11	DATE
fsns-1447	202	2	2353-2359	DATE
fsns-1447	203	1	m. (1990	ORG
fsns-1447	204	1	-amylase	PERSON
fsns-1447	205	1	54(8	CARDINAL
fsns-1447	205	2	1939-1945	DATE
fsns-1447	206	1	https://doi.org/10.1080/00021369.1990.10870239 hayashi	PERSON
fsns-1447	206	2	i.	PERSON
fsns-1447	206	3	nixon	PERSON
fsns-1447	206	4	t.	GPE
fsns-1447	206	5	morikawa	ORG
fsns-1447	206	6	m., & green, h. (1981	ORG
fsns-1447	207	1	the national academy of sciences	ORG
fsns-1447	207	2	the united states of america	GPE
fsns-1447	207	3	78(6	DATE
fsns-1447	208	1	ichikawa	GPE
fsns-1447	208	2	2006	DATE
fsns-1447	209	1	japanese	NORP
fsns-1447	210	1	6(5	CARDINAL
fsns-1447	210	2	257	CARDINAL
fsns-1447	211	1	k., yamaki	PERSON
fsns-1447	211	2	k., & tsushida	ORG
fsns-1447	211	3	t.	GPE
fsns-1447	211	4	2001	DATE
fsns-1447	212	1	3t3	CARDINAL
fsns-1447	213	1	7(2	CARDINAL
fsns-1447	213	2	154	CARDINAL
fsns-1447	214	1	jakobek	PERSON
fsns-1447	214	2	l.	PERSON
fsns-1447	214	3	2015	DATE
fsns-1447	216	1	175	CARDINAL
fsns-1447	216	2	556	CARDINAL
fsns-1447	216	3	m. p.	PERSON
fsns-1447	216	4	hopia	GPE
fsns-1447	216	5	a. i.	PERSON
fsns-1447	216	6	vuorela	PERSON
fsns-1447	216	7	h. j.	PERSON
fsns-1447	216	8	j. p.	PERSON
fsns-1447	216	9	kujala	GPE
fsns-1447	216	10	t. s.	GPE
fsns-1447	216	11	m. (	PERSON
fsns-1447	216	12	1999	DATE
fsns-1447	218	1	47	DATE
fsns-1447	218	2	3954-3962	CARDINAL
fsns-1447	219	1	kuri-harcuch	PERSON
fsns-1447	219	2	w., & green	ORG
fsns-1447	219	3	1978	DATE
fsns-1447	220	1	3t3	CARDINAL
fsns-1447	222	1	2	CARDINAL
fsns-1447	222	2	2	CARDINAL
fsns-1447	222	3	2018 24	DATE
fsns-1447	222	4	scholink inc.	ORG
fsns-1447	222	5	the national academy of sciences	ORG
fsns-1447	222	6	the united states of america	GPE
fsns-1447	222	7	6107-6109	DATE
fsns-1447	223	1	https://doi.org/10.1073/pnas.75.12.6107	ORG
fsns-1447	223	2	c. s.	PERSON
fsns-1447	223	3	sohn, h. y.	ORG
fsns-1447	223	4	kim	PERSON
fsns-1447	223	5	s. h.	PERSON
fsns-1447	223	6	kim	PERSON
fsns-1447	223	7	j. h.	PERSON
fsns-1447	223	8	k. h.	PERSON
fsns-1447	223	9	lee	PERSON
fsns-1447	223	10	j. s.	PERSON
fsns-1447	223	11	kim	PERSON
fsns-1447	223	12	j. s.	PERSON
fsns-1447	223	13	2003	DATE
fsns-1447	224	1	dioscorea nipponica makino	ORG
fsns-1447	225	1	67(7	DATE
fsns-1447	225	2	1451-1456	CARDINAL
fsns-1447	226	1	https://doi.org/10.1271/bbb.67.1451 lu	PERSON
fsns-1447	226	2	w., kelly	PERSON
fsns-1447	226	3	a. l.	PERSON
fsns-1447	226	4	s.	PERSON
fsns-1447	226	5	2016	CARDINAL
fsns-1447	228	1	47	DATE
fsns-1447	228	2	1	CARDINAL
fsns-1447	228	3	g. j.	PERSON
fsns-1447	228	4	f.	PERSON
fsns-1447	228	5	dobson	PERSON
fsns-1447	228	6	blake, a., & stewart	ORG
fsns-1447	228	7	d. (	GPE
fsns-1447	228	8	2005	DATE
fsns-1447	229	1	-glucosidase	ORG
fsns-1447	230	1	53	DATE
fsns-1447	230	2	2760-2766	CARDINAL
fsns-1447	231	1	saito	PERSON
fsns-1447	231	2	s.	GPE
fsns-1447	231	3	h.	PERSON
fsns-1447	231	4	k., & kojima	ORG
fsns-1447	231	5	m.	PERSON
fsns-1447	231	6	2007	DATE
fsns-1447	232	1	-amylase	PERSON
fsns-1447	232	2	-glucosidase	ORG
fsns-1447	232	3	japanese	NORP
fsns-1447	233	1	nippon	GPE
fsns-1447	233	2	kagaku kogaku kaishi	PERSON
fsns-1447	233	3	54(12	CARDINAL
fsns-1447	233	4	563	CARDINAL
fsns-1447	234	1	https://doi.org/10.3136/nskkk.54.563	ORG
fsns-1447	234	2	s.	PERSON
fsns-1447	234	3	1998	DATE
fsns-1447	235	1	3t3	CARDINAL
fsns-1447	235	2	japanese	NORP
fsns-1447	236	1	nippon	GPE
fsns-1447	236	2	51(6	CARDINAL
fsns-1447	236	3	361	CARDINAL
fsns-1447	237	1	https://doi.org/10.4327/jsnfs.51.361 urabe	PERSON
fsns-1447	237	2	kitao	PERSON
fsns-1447	237	3	kouyama	PERSON
fsns-1447	237	4	k.	PERSON
fsns-1447	237	5	nadamoto	GPE
fsns-1447	237	6	t.	GPE
fsns-1447	237	7	kawamura	ORG
fsns-1447	237	8	m., & nishikawa	ORG
fsns-1447	237	9	2003	DATE
fsns-1447	238	1	japanese	NORP
fsns-1447	239	1	nippon	GPE
fsns-1447	239	2	kagaku kogaku kaishi	PERSON
fsns-1447	239	3	50(8	DATE
fsns-1447	239	4	350	CARDINAL
fsns-1447	240	1	https://doi.org/10.3136/nskkk.50.350 yamashoji	GPE
fsns-1447	240	2	s.	GPE
fsns-1447	240	3	yoshida, h., & kajimoto	ORG
fsns-1447	240	4	1979	DATE
fsns-1447	242	1	43(6	CARDINAL
fsns-1447	242	2	1249-1254	CARDINAL